Mention in Nature Biotechnology's paper
InnovationActa
The B-specific consortium is proud to be mentioned in a recent paper in Nature Biotechnology entitled “The European Innovation Council supports innovative portfolios in health biotech” LINK to paper and we would like to thank Iordanis Arzimanoglou for his work.
The European Innovation Council (EIC) was officially launched in March 2021 with the aim of creating an ecosystem that promotes deep-tech, science-based businesses by leveraging European research and development initiatives and unlocking Europe’s innovative potential. B-specific is participating in the EIC Cardiogenomics Challenge, which seeks to enhance the correlation between the well-established pathology of heart disease and various biomarkers.
The EIC Cardiogenomics portfolio is designed to offer valuable, interdisciplinary insights into how known and newly identified polymorphisms contribute to the susceptibility, onset, and progression of various forms of cardiovascular disease.
Here you can find the link: to open access version of the paper
ABC research presented at the Imperial Vulnerable Plaque and Patient 2024 meeting
InnovationActa
On the 23rd of September, Amanda Foks was invited to present her research findings on age-associated immunity, including ABCs, in atherosclerosis, online at the Imperial Vulnerable Plaque and Patient meeting (VPM2024), which took place at Sevilla, Spain. The meeting was broadcasted online.
Best poster presentation award for Jill de Mol at the GEMseq 2024 meeting
InnovationActa
During the 6th edition of the Graz Expert Meeting on Single-cell sequencing technologies in the cardiovascular field, held on September 15 and 16 in Graz, Austria, Jill de Mol from the group of Amanda Foks from Leiden University received the award for best poster presentation.
During this annual symposium, organized at the Medical University of Graz, basic scientists and clinicians were invited to present and discuss their recent advances with single cell sequencing technologies in the field of atherosclerosis. Amanda was invited to present her work on ‘Single cell profiling of age-associated immunity in atherosclerosis’. During the poster session, Jill de Mol presented her work on age-associated B cells as pro-atherogenic drivers in murine atherosclerosis and their association with human coronary events.
COSTaction network AtheroNET
InnovationActa
On September 15th 2024 Assoc. Prof. Bram Slütter (ULEI) provided an online seminar, entitled ‘Resident memory cells in atherosclerosis’ for the COSTaction network AtheroNET
Webinar European Society of Cardiology
InnovationActa
During an online webinar on inflammation in atherosclerosis, organized by the European Society of Cardiology, Ilze Bot lectured on the use and application of single-cell RNA sequencing in atherosclerosis. She specifically discussed two cases where such data can be of interest in target discovery and for mechanistic insight, also related to B cells.
ESC Congress 2024
InnovationActa
Prof. Maryam Kavousi (EMC) participated at the congress of the European Society of Cardiology (ESC Congress 2024) held in London between 30th August and 2nd September 2024.
Prof. Kavousi gave the two following talks
Do genetic scores help risk stratify in primary prevention?
LINK to slides
Prevention: personalising cardiovascular prevention
LINK to slides
The slides can be accessed via the links after sign in
Webinar European Vascular Biology Meeting
InnovationActa
On June 18, Ilze Bot participated in the monthly webinar organized by the European Vascular Biology Meeting. She presented her work on mast cells in cardiovascular disease, also referring to antibodies and antigens that may activate these cells, in relation to the B-specific work.
KUL team participation at conferences in May -June 2024
InnovationActa
American Society of Gene & Cell Therapy
Nick Geukens from the KUL team took part in the American Society of Gene & Cell Therapy 27th Annual Meeting held between 7th and 11th May 2024 in Baltimore, United States
The KUL team presented their work related to unraveling the multifactorial host immune response triggered by intramuscular electrotransfer of a DNA-encoded antibody.
Biotech conference in the Benelux
Members of the KUL team joined in the biggest biotech conference in the BeNeLux, Knowledge for Growth, held between 15th and 16th May 2024 in Antwerpen, Belgium.
“Antigen-Specific Immune Monitoring of T Cells, B Cells, and Non-conventional Immune Cells” Conference
On the 12th of June 2024, Nick Geukens from the KUL team participated in the conference dedicated to “Antigen-Specific Immune Monitoring of T Cells, B Cells, and Nonconventional Immune Cells”. The event was held in Amsterdam, Netherlands.
To view more
American Society of Gene & Cell Therapy
Baltimore – United States
go to the website: https://annualmeeting.asgct.org/
Biotech conference in the BeNeLux
Antwerpen – Belgium
go to the website: https://knowledgeforgrowth.be/
“Antigen-Specific Immune Monitoring of T Cells, B Cells, and Non-conventional Immune Cells” Conference
Amsterdam, Netherlands.
go to the website: https://www.immudex.com/
Jill de Mol receives best presentation award at the Dutch Atherosclerosis Society Symposium 2024
InnovationActa
At the 2024 Dutch Atherosclerosis Society Symposium, held on May 23rd in Zeist, Jill de Mol from the Division of BioTherapeutics received the award for best oral presentation for her work on age-associated B cells in atherosclerosis.
During this annual symposium, organized by the Dutch Atherosclerosis Society board, basic scientists and clinicians present and discuss their recent developments in the field of atherosclerosis research. Almost the entire cardiovascular ULEI lab attended this meeting and contributed to the program. B-specific member Ilze Bot provided the keynote lecture entitled ‘Mast cells as effectors in advanced atherosclerosis’. Amanda Foks presented her research on ‘Sexual dimorphism in atherosclerotic plaques of aged Ldlr deficient mice’ and Jill de Mol presented our progress on age-associated B cells in atherosclerosis in the session of selected abstracts.
